Press Release: DRUGSCAN : In Vitro "Chewing" Studies May Differentiate Abuse-Deterrent Formulations Suggests New Research from DRUGSCAN® and PinneyAssociates

HORSHAM, Pa., Aug. 29, 2017 /PRNewswire/ -- Pharmaceutical companies developing abuse-deterrent formulations may be able to assess a formulation's ability to resist chewing, according to results of an in vitro "chewing" study conducted by DRUGSCAN© Pharmaceutical Services, leaders in...